Controlled dose drug delivery system
DC CAFCFirst Claim
Patent Images
1. A method for treating attention deficit hyperactivity disorder (ADHD) which comprises:
- administering to a patient in need thereof, a pharmaceutical composition comprising;
(a) an immediate release bead comprising at least one amphetamine salt;
(b) a first delayed release bead comprising at least one amphetamine salt; and
(c) a second delayed release bead comprising at least one amphetamine salt;
wherein the first delayed release bead provides pulsed release of the at least one amphetamine salt and the second delayed release bead provides sustained release of the at least one amphetamine salt;
wherein the second delayed release bead comprises at least one amphetamine salt layered onto or incorporated into a core;
a delayed release coating layered onto the amphetamine core; and
a sustained release coating layered onto the delayed release coating, wherein the sustained release coating is pH-independent; and
wherein the first delayed release bead and the second delayed release bead comprise an enteric coating.
2 Assignments
Litigations
1 Petition
Accused Products
Abstract
A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising a pharmaceutically active amphetamine salt covered with an immediate-release coating and a pharmaceutically active amphetamine salt covered with an enteric coating wherein the immediate release coating and the enteric coating provide for multiple pulsed dose delivery of the pharmaceutically active amphetamine salt. The product can be composed of either one or a number of beads in a dosage form, including either capsule, tablet, or sachet method for administering the beads.
31 Citations
29 Claims
-
1. A method for treating attention deficit hyperactivity disorder (ADHD) which comprises:
-
administering to a patient in need thereof, a pharmaceutical composition comprising; (a) an immediate release bead comprising at least one amphetamine salt; (b) a first delayed release bead comprising at least one amphetamine salt; and (c) a second delayed release bead comprising at least one amphetamine salt;
wherein the first delayed release bead provides pulsed release of the at least one amphetamine salt and the second delayed release bead provides sustained release of the at least one amphetamine salt;wherein the second delayed release bead comprises at least one amphetamine salt layered onto or incorporated into a core;
a delayed release coating layered onto the amphetamine core; and
a sustained release coating layered onto the delayed release coating, wherein the sustained release coating is pH-independent; andwherein the first delayed release bead and the second delayed release bead comprise an enteric coating. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
Specification